Suzuki K - Search Results

1

Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.

Suzuki K, Tsukada N, Nishimura N, Nagata Y, Okazuka K, Mishima Y, Yokoyama M, Nishiwaki K, Ishida T, Yano S, Terui Y, Suzuki K. Suzuki K, et al. Int J Hematol. 2020 Jan;111(1):103-111. doi: 10.1007/s12185-019-02764-1. Epub 2019 Oct 30. Int J Hematol. 2020. PMID: 31673952

2

Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.

Abe Y, Muto M, Nieda M, Nakagawa Y, Nicol A, Kaneko T, Goto S, Yokokawa K, Suzuki K. Abe Y, et al. Among authors: suzuki k. Exp Hematol. 2009 Aug;37(8):956-68. doi: 10.1016/j.exphem.2009.04.008. Epub 2009 May 4. Exp Hematol. 2009. PMID: 19409955 Free article. Clinical Trial.

3

Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS).

Oshima K, Takahashi W, Asano-Mori Y, Izutsu K, Takahashi T, Arai Y, Nakagawa Y, Usuki K, Kurokawa M, Suzuki K, Mitani K, Kanda Y. Oshima K, et al. Among authors: suzuki k. Ann Hematol. 2012 Oct;91(10):1533-9. doi: 10.1007/s00277-012-1487-1. Epub 2012 May 11. Ann Hematol. 2012. PMID: 22576311

4

[Increased level of KL-6 in a BJP-λ-type multiple myeloma patient with poor prognosis].

Nakagawa Y, Iizuka H, Nishiyama S, Abe Y, Kusaka S, Sekine R, Suzuki K. Nakagawa Y, et al. Among authors: suzuki k. Rinsho Ketsueki. 2012 May;53(5):521-5. Rinsho Ketsueki. 2012. PMID: 22728554 Japanese.

5

[Clinical analysis of autologous stem cell transplantation for nine cases of cardiac amyloidosis].

Ogura M, Sekine R, Nishiyama S, Abe Y, Iizuka H, Kusaka S, Nakagawa Y, Suzuki K. Ogura M, et al. Among authors: suzuki k. Rinsho Ketsueki. 2012 Jul;53(7):710-5. Rinsho Ketsueki. 2012. PMID: 22975774 Japanese.

6

Current therapeutic strategy for multiple myeloma.

Suzuki K. Suzuki K. Jpn J Clin Oncol. 2013 Feb;43(2):116-24. doi: 10.1093/jjco/hys215. Epub 2013 Jan 4. Jpn J Clin Oncol. 2013. PMID: 23293370 Review.

7

Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.

Ogawa Y, Suzuki K, Sakai A, Iida S, Ogura M, Tobinai K, Matsumoto M, Matsue K, Terui Y, Ohashi K, Ishii M, Mukai HY, Ando K, Hotta T. Ogawa Y, et al. Among authors: suzuki k. Cancer Sci. 2013 Jul;104(7):912-9. doi: 10.1111/cas.12172. Epub 2013 May 27. Cancer Sci. 2013. PMID: 23574271 Free PMC article. Clinical Trial.

8

[Primary systemic AL amyloidosis with remarkable calcification in the spleen].

Uchiyama K, Tsukada N, Miyazaki K, Abe Y, Sekine R, Nakagawa Y, Suzuki K. Uchiyama K, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 Mar;55(3):334-9. Rinsho Ketsueki. 2014. PMID: 24681937 Japanese.

9

[Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].

Hamano A, Shingaki S, Abe Y, Miyazaki K, Sekine R, Nakagawa Y, Tsukada N, Hattori Y, Suzuki K. Hamano A, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 Apr;55(4):428-35. Rinsho Ketsueki. 2014. PMID: 24850453 Japanese.

10

[Effective control of skin reaction by air sandwich technique in a patient with IgE-κ myeloma treated with subcutaneous bortezomib injection].

Honda Y, Inoue J, Shingaki S, Miyazaki K, Abe Y, Sekine E, Iki S, Tsukada N, Suzuki K. Honda Y, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 May;55(5):570-2. Rinsho Ketsueki. 2014. PMID: 24881924 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,663 results

Search Page

Filters